CRYOTHERAPY MARKET ANALYSIS

Cryotherapy Market, By Product [Cryosurgery Devices (Cryo Probes, Cryoablation Devices), Localized Cryotherapy Devices, Cryochambers, and Cryosaunas], By Application (Cancer, Cardiovascular Diseases, Dermatologic Disorders, Pain Management, and Others), By End User [Hospitals, Specialty Clinics, and Others (Spas and Fitness Centers)], and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Sep 2023
Code : CMI133
Pages :220
Formats :
Excel and PDF
Industry : Medical Devices

Market News

Global Cryotherapy Market: Key Developments

Increasing product launches by key players in the market are expected to drive the market growth over the forecast period. For instance, on August 8, 2023, Boston Scientific Corporation, a medical technology company, announced that it has received the U.S. Food and Drug Administration (FDA) approval for the POLARx Cryoablation System.

On May 31, 2023, IceCure Medical Ltd, a developer of the ProSense System, a minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, announced that ProSense was recently installed and inaugurated at Kovai Medical Center and Hospital (KMCH) in Coimbatore, India.

On May 10 2023, Varian, a Siemens Healthineers company which is a medical technology company announced the launch of the Isolis cryoprobe, a single use, and disposable device designed for use with CryoCare systems that seeks to improve procedural efficiency and precision for cryoablation.

In February 2022, Medtronic, a healthcare technology company, announced that the Freezor and Freezor Xtra Cardiac Cryoablation Focal Catheters are the first and only ablation catheters approved by the U.S. Food and Drug Administration (FDA) to treat the growing prevalence of pediatric Atrioventricular Nodal Reentrant Tachycardia (AVNRT).